Table 3.
Adverse events (AEs)
| Total (N = 198) | Valaciclovir (n = 97) | Placebo (n = 101) | P value | |
|---|---|---|---|---|
| Any ≥possibly drug-related AEs ≥grade 2 | 13 (6.57) | 6 (6.19) | 7 (6.93) | 0.83 |
| Any ≥possibly drug-related AEs ≥grade 3 | 4 (2.02) | 3 (3.09) | 1 (0.99) | 0.36 |
| Any ≥probably drug-related AEs ≥grade 2 | 3 (1.52) | 2 (2.06) | 1 (0.99) | 0.62 |
| Number of possibly drug-related AEs ≥grade 2 | ||||
| 0 | 185 (93.4) | 91 (93.8) | 94 (93.1) | 0.70 |
| 1 | 8 (4.04) | 3 (3.09) | 5 (4.95) | |
| 2 | 4 (2.02) | 2 (2.06) | 2 (1.98) | |
| 4 | 1 (0.51) | 1 (1.03) | 0 (0) |
All values shown are n (%).